Human Immunodeficiency Virus Type 1 Vpu Protein Regulates the Formation of Intracellular Gp160-CD4 Complexes

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1992 Jan 1

PMID 1727486

Citations 114

Authors

R L Willey

F Maldarelli

M A Martin

K Strebel

Affiliations

Soon will be listed here.

Abstract

Intracellular transport and processing of the human immunodeficiency virus type 1 (HIV-1) envelope precursor glycoprotein, gp160, proceeds via the endoplasmic reticulum and Golgi complex and involves proteolytic processing of gp160 into the mature virion components, gp120 and gp41. We found that coexpression of gp160 and human CD4 in HeLa cells severely impaired gp120 production due to the formation of intracellular gp160-CD4 complexes. This CD4-mediated inhibition of gp160 processing was alleviated by coexpression of the HIV-1-encoded Vpu protein. The coexpression of Vpu and CD4 in the presence of gp160 resulted in increased degradation of CD4. Although the precise mechanism(s) responsible for the Vpu effect is presently unclear, our findings suggest that Vpu may destabilize intracellular gp160-CD4 complexes.

Citing Articles

Double-Negative T-Cells during Acute Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections and Following Early Antiretroviral Therapy Initiation.

Yero A, Shi T, Clain J, Zghidi-Abouzid O, Racine G, Costiniuk C Viruses. 2024; 16(10).

PMID: 39459942 PMC: 11512404. DOI: 10.3390/v16101609.

CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies.

Richard J, Sannier G, Zhu L, Prevost J, Marchitto L, Benlarbi M mBio. 2024; 15(11):e0182724.

PMID: 39373535 PMC: 11559134. DOI: 10.1128/mbio.01827-24.

Development and Prospects of Furin Inhibitors for Therapeutic Applications.

Ivachtchenko A, Khvat A, Shkil D Int J Mol Sci. 2024; 25(17).

PMID: 39273149 PMC: 11394684. DOI: 10.3390/ijms25179199.

No detectable differences in Nef-mediated downregulation of HLA-I and CD4 molecules among HIV-1 group M lineages circulating in Cameroon, where the pandemic originated.

Sonela N, Mann J, Godwe C, Goni O, Tchakoute M, Nkoue N Front Virol. 2024; 4.

PMID: 38883214 PMC: 7616105. DOI: 10.3389/fviro.2024.1379217.

Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Gargan S, Stevenson N Viruses. 2021; 13(11).

PMID: 34834972 PMC: 8618147. DOI: 10.3390/v13112165.

References

Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T . T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984; 312(5996):767-8. DOI: 10.1038/312767a0. View

Strebel K, Klimkait T, Martin M . A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science. 1988; 241(4870):1221-3. DOI: 10.1126/science.3261888. View

Stevenson M, Zhang X, Volsky D . Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J Virol. 1987; 61(12):3741-8. PMC: 255987. DOI: 10.1128/JVI.61.12.3741-3748.1987. View

Stein B, Engleman E . Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem. 1990; 265(5):2640-9. View

Buonocore L, Rose J . Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature. 1990; 345(6276):625-8. DOI: 10.1038/345625a0. View

Romieu I, Marlink R, Kanki P, Mboup S, Essex M . HIV-2 link to AIDS in West Africa. J Acquir Immune Defic Syndr (1988). 1990; 3(3):220-30. View

Klimkait T, Strebel K, HOGGAN M, Martin M, Orenstein J . The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol. 1990; 64(2):621-9. PMC: 249152. DOI: 10.1128/JVI.64.2.621-629.1990. View

Daar E, Li X, Moudgil T, Ho D . High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci U S A. 1990; 87(17):6574-8. PMC: 54579. DOI: 10.1073/pnas.87.17.6574. View

Layne S, Merges M, Dembo M, Spouge J, Nara P . HIV requires multiple gp120 molecules for CD4-mediated infection. Nature. 1990; 346(6281):277-9. DOI: 10.1038/346277a0. View

10.

Gorman C, Merlino G, Willingham M, Pastan I, Howard B . The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci U S A. 1982; 79(22):6777-81. PMC: 347216. DOI: 10.1073/pnas.79.22.6777. View

11.

Graham F, Van Der Eb A . A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973; 52(2):456-67. DOI: 10.1016/0042-6822(73)90341-3. View

12.

Willey R, Klimkait T, Frucht D, Bonifacino J, Martin M . Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology. 1991; 184(1):319-29. DOI: 10.1016/0042-6822(91)90848-6. View

13.

Sugrue R, Hay A . Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology. 1991; 180(2):617-24. PMC: 7131614. DOI: 10.1016/0042-6822(91)90075-m. View

14.

Sugrue R, Bahadur G, Zambon M, Douglas A, Hay A . Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO J. 1990; 9(11):3469-76. PMC: 552095. DOI: 10.1002/j.1460-2075.1990.tb07555.x. View

15.

Culp J, Chaikin M, Hellmig B, Matthews T, Sweet R, Rosenberg M . Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A. 1991; 88(2):512-6. PMC: 50841. DOI: 10.1073/pnas.88.2.512. View

16.

Cloyd M, Lynn W . Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology. 1991; 181(2):500-11. DOI: 10.1016/0042-6822(91)90882-c. View

17.

Moore J, McKeating J, Norton W, Sattentau Q . Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4. J Virol. 1991; 65(3):1133-40. PMC: 239879. DOI: 10.1128/JVI.65.3.1133-1140.1991. View

18.

Crise B, Buonocore L, Rose J . CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor. J Virol. 1990; 64(11):5585-93. PMC: 248611. DOI: 10.1128/JVI.64.11.5585-5593.1990. View

19.

Schwartz S, Felber B, Fenyo E, Pavlakis G . Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol. 1990; 64(11):5448-56. PMC: 248596. DOI: 10.1128/JVI.64.11.5448-5456.1990. View

20.

Maddon P, Dalgleish A, McDougal J, Clapham P, Weiss R, Axel R . The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986; 47(3):333-48. DOI: 10.1016/0092-8674(86)90590-8. View